15 Wealth Advisors LLC’s Edwards Lifesciences EW Stock Holding History

15 Wealth Advisors LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.74M	Buy	+31,770	New	+$2.82M	0.69%	34

Other funds holding EW

SIM

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return

Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Equitable Trust Nashville, Tennessee $2.38B AUM 22.38% 1-Year Est. Return

15 Wealth Advisors LLC's EW Position: Q3 2026 in Review

15 Wealth Advisors LLC opened a new position in Edwards Lifesciences (EW) in Q3 2026: 31,770 shares worth $2.74M. The stake represents 0.69% of the portfolio and ranks #34 among its holdings.

121 funds tracked by Wall St. Rank hold EW as of Q3 2026.

15 Wealth Advisors LLC held 31,770 shares of Edwards Lifesciences worth $2.74M as of Q3 2026.
Edwards Lifesciences was a new 15 Wealth Advisors LLC position in Q3 2026.
Edwards Lifesciences made up 0.69% of 15 Wealth Advisors LLC's portfolio in Q3 2026, its #34 holding.
121 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on 15 Wealth Advisors LLC's 13F filing for Q3 2026, filed 14 Oct 2026.